Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: Results of a double-blind randomized study

Surgical Infections

Volumn 8, Issue 1, 2007, Pages 83-90

  Claridge, Jeffrey A ^a,b   Edwards, Norma M ^a   Swanson, Joseph ^a   Fabian, Timothy C ^a   Weinberg, Jordan A ^a   Wood, Christopher ^a   Croce, Martin A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; PLACEBO;

ADULT; AEROSOL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION PREVENTION; INJURY SCALE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

ADMINISTRATION, INHALATION; ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIA; BACTERIAL INFECTIONS; CEFTAZIDIME; DOUBLE-BLIND METHOD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; MALE; PLACEBOS; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 34247132154     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.042     Document Type: Article

References (25)

1. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-440.
2. Croce MA, Fabian TC, Waddle-Smith L, Maxwell RA. Identification of early predictors for post-traumatic pneumonia. Am Surg 2001;67:105-110.
3. Rello J, Ausina V, Castella J, et al. Nosocomial respiratory tract infections in multiple trauma patients: Influence of level of consciousness with implications for therapy. Chest 1992;102:525-529.
4. Rodriguez JL, Gibbons KJ, Bitzer LG, et al. Pneumonia: Incidence, risk factors, and outcome in injured patients. J Trauma 1991;31:907-914.
5. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281-288.
6. Fagon JY, Chastre J, Vuagnat A, et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996;275:866-869.
7. Gross PA, Van Antwerpen C. Nosocomial infections and hospital deaths: A case-control study. Am J Med 1983;75:658-662.
8. Hsieh AH, Bishop MJ, Kubilis PS, et al. Pneumonia following closed head injury. Am Rev Respir Dis 1992;146:290-294.
9. Leu HS, Kaiser DL, Mori M, et al. Hospital-acquired pneumonia: Attributable mortality and morbidity. Am J Epidemiol 1989;129:1258-1267.
10. Magnotti LJ, Croce MA, Fabian TC. Is ventilator-associated pneumonia in trauma patients an epiphenomenon or a cause of death? Surg Infect 2004;5: 237-242.
11. Markowicz P, Wolff M, Djedaini K, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome: Incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 2000;161:1942-1948.
12. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142:523-528.
13. Klastersky J, Hensgens C, Noterman J, et al. Endotracheal antibiotics for the prevention of tracheobronchial infections in tracheotomized unconscious patients: A comparative study of gentamicin and aminosidin-polymyxin B combination. Chest 1975; 68:302-306.
14. Klastersky J, Huysmans E, Weerts D, et al. Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: A double-blind study. Chest 1974;65:650-654.
15. Klick JM, du Moulin GC, Hedley-Whyte J, et al. Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis II: Effect on the incidence of pneumonia in seriously ill patients. J Clin Invest 1975;55:514-519.
16. Rathgeber J, Zielmann S, Panzer C, Burchardi H. [Prevention of pneumonia by endotracheal micronebulization of tobramycin]. Anästhesiol Intensivmed Notfallmed Schmerzther 1993;28:23-29.
17. Rouby JJ, Poete P, Martin de Lassale E, et al. Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients: Histologic and bacteriologic study. Intensive Care Med 1994;20:187-192.
18. Wood GC, Boucher BA, Croce MA, et al. Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients. Pharmacotherapy 2002;22:972-982.
19. Bressolle F, de la Coussaye JE, Ayoub R, et al. Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: Pharmacokinetics and absolute bioavailability. Antimicrob Agents Chemother 1992;36:1404-1411.
20. Palmer LB, Smaldone GC, Simon SR, et al. Aerosolized antibiotics in mechanically ventilated patients: Delivery and response. Crit Care Med 1998; 26:31-39.
21. Croce MA, Tolley EA, Fabian TC. A formula for prediction of posttraumatic pneumonia based on early anatomic and physiologic parameters. J Trauma 2003; 54:724-730.
22. Croce MA, Fabian TC. Monotherapy of gram-negative nosocomial pneumonia. J Term Med Assoc 1993; 86:353-354.
23. Croce MA, Fabian TC, Schurr MJ, et al. Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: A prospective analysis. J Trauma 1995;39: 1134-1140.
24. Mueller EW, Hanes SD, Croce MA, et al. Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients. J Trauma 2005;58:94-101.
25. Feeley TW, Du Moulin GC, Hedley-Whyte J, et al. Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975;293:471-475.